Capital Advantage’s Clorox CLX Stock Holding History

Capital Advantage’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,420	Closed	-$214K	–	73
2018 Q3	$214K	Buy	+1,420	New	+$202K	0.05%	75
2018 Q1	–	Sell	-1,623	Closed	-$241K	–	76
2017 Q4	$241K	Hold	1,623	–	–	0.06%	70
2017 Q3	$214K	Hold	1,623	–	–	0.05%	75
2017 Q2	$216K	Hold	1,623	–	–	0.06%	70
2017 Q1	$219K	Buy	+1,623	New	+$210K	0.06%	75
2016 Q2	–	Sell	-1,631	Closed	-$206K	–	78
2016 Q1	$206K	Hold	1,631	–	–	0.07%	71
2015 Q4	$207K	Buy	+1,631	New	+$202K	0.07%	74

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Advantage's CLX Position: Q4 2018 in Review

Capital Advantage sold out of Clorox (CLX) in Q4 2018, closing a stake of 1,420 shares — an estimated $214K sold.

Capital Advantage first reported a position in CLX in Q4 2015 and held it in 7 quarters. The position peaked at $241K in Q4 2017. 989 funds tracked by Wall St. Rank hold CLX as of Q4 2018.

Capital Advantage reported no remaining Clorox position as of Q4 2018 after selling out during the quarter.
Capital Advantage sold 1,420 Clorox shares in Q4 2018, an estimated $214K.
Capital Advantage first reported a position in Clorox in Q4 2015 and held it in 7 quarters.
Capital Advantage's Clorox position peaked at $241K in Q4 2017.
989 funds tracked by Wall St. Rank held Clorox as of Q4 2018.

Based on Capital Advantage's 13F filing for Q4 2018, filed 7 Feb 2019.